Gossamer Bio
GOSS
GOSS
88 hedge funds and large institutions have $632M invested in Gossamer Bio in 2019 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 30 increasing their positions, 22 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
9% less capital invested
Capital invested by funds: $694M → $632M (-$62M)
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
91% less call options, than puts
Call options by funds: $1.53M | Put options by funds: $16.4M
Holders
88
Holding in Top 10
1
Calls
$1.53M
Puts
$16.4M
Top Buyers
| 1 | +$14M | |
| 2 | +$11.6M | |
| 3 | +$6.24M | |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
+$5.61M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$3.45M |
Top Sellers
| 1 | -$15.9M | |
| 2 | -$13.9M | |
| 3 | -$13.8M | |
| 4 |
OFM
Omega Fund Management
Boston,
Massachusetts
|
-$6.78M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$6.66M |